LIBBY HANDEL, Ph.D.

Libby Handel is the Head of Strategy of the Belfer Neurodegeneration Consortium at MD Anderson Cancer Center. Before joining the BNDC, she was Director of Business Development at Torrey Pines Institute for Molecular Studies. She has 20 years of experience in technology commercialization, partnering, intellectual property management and start-ups. She holds PhD in Molecular Biology and MS in Neuroscience.